Vlad Coric, Chief Executive Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 123,950 shares at $29.04 ($3.6M) on 2017-10-31, disclosed to the SEC on 2017-11-02.
Open-market sale of $3.6M BHVN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.04 | 25,827 | $750K | 20.6% |
| 2 | $29.04 | 25,828 | $750K | 20.6% |
| 3 | $29.96 | 23,123 | $693K | 19.0% |
| 4 | $29.96 | 23,122 | $693K | 19.0% |
| 5 | $30.51 | 1,050 | $32K | 0.9% |
| 6 | $29.10 | 18,074 |
| $526K |
| 14.4% |
| 7 | $29.62 | 6,926 | $205K | 5.6% |
| Total | $29.44 avg | 123,950 | $3.6M | 100% |
| Filing → |
| BHVN | BUY | 2024-10-03 | $1000K | — | Filing → |
| BHVN | BUY | 2024-04-23 | $5.0M | — | Filing → |
| BHVN | BUY | 2023-10-10 | $10.0M | — | Filing → |